Cross-tabulations of PGA×BSA 75% and PASI 75 response achievement at Week 24 (observed case data; all patients with ≥ 3% psoriasis BSA at baseline).
| PGA×BSA75 | ||||
|---|---|---|---|---|
| Yes | No | Total | ||
| PASI75 | Yes | 102 (54.8) | 12 (6.5) | 114 (61.3) |
| No | 18 (9.7) | 54 (29.0) | 72 (38.7) | |
| Total | 120 (64.5) | 66 (35.5) | ||
Shaded numbers = agreement in responses: 83.8%. Bold face numbers = disagreement in responses: 16.2%. Sensitivity of PGA×BSA75 relative to PASI75 = 89.5%, specificity = 75.0%, diagnostic OR = 25.5.